← Back
$LYEL All transactions

Lyell Immunopharma, Inc.

A

$ Value

$0

Shares

43,750

Price

$0

Filed

Jun 11

Insider

Name

Shook David

Title

Chief Medical Officer

CIK

0001959742

Roles

Officer

Transaction Details

Transaction Date

2025-06-09

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

43,750

Footnotes

Represents restricted stock units granted under the Issuer's 2021 Equity Incentive Plan ("RSUs"). 25% of the total shares subject to the RSUs will vest on June 9, 2026, and an additional 1/16th of the total shares subject to the RSUs per quarter thereafter, subject to the reporting person providing service through the applicable vesting date. | 25% of the option shares will vest on June 9, 2026, with the remaining option shares to vest in equal monthly installments over the following thirty-six months, subject to the reporting person providing service through the applicable vesting date.

Filing Info

Accession No.

0001415889-25-016728

Form Type

4

Issuer CIK

0001806952

Shook David's History

Date Ticker Type Value
2025-06-09 LYEL A $0
2025-06-09 LYEL A $0

Other Insiders at LYEL (90d)

No other insider activity at this issuer in the last 90 days.